GS
IDNA icon

GTS Securities’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

GTS Securities’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,301
Closed -$677K – 1599
2026
Q1 		$677K Buy
+23,301
New +$676K 0.02% 564
2024
Q3 		– Sell
-10,027
Closed -$232K – 4239
2024
Q2 		$232K Buy
+10,027
New +$235K ﹤0.01% 3323

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
TF
Trek Financial Scottsdale, Arizona $2.01B AUM 53.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GTS Securities's IDNA Position: Q2 2026 in Review

GTS Securities sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q2 2026, closing a stake of 23,301 shares — an estimated $677K sold.

GTS Securities first reported a position in IDNA in Q2 2024 and held it in 2 quarters. The position peaked at $677K in Q1 2026. 66 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

  • GTS Securities reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q2 2026 after selling out during the quarter.
  • GTS Securities sold 23,301 iShares Genomics Immunology and Healthcare ETF shares in Q2 2026, an estimated $677K.
  • GTS Securities first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2024 and held it in 2 quarters.
  • GTS Securities's iShares Genomics Immunology and Healthcare ETF position peaked at $677K in Q1 2026.
  • 66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.